Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes
Halo340B Launches Innovative AI-Powered Platform to Strengthen 340B Compliance and Optimize Revenue for Healthcare Providers
By delivering a seamless, automated solution, Halo340B eliminates the complexities of program compliance while uncovering missed opportunities to significantly increase revenue for covered entities


















